
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
VelaVigo was founded by Dr. Jing Li, a renowned biopharma executive, in October 2021. We leverage discovery as an innovative engine with an emphasis on novel technologies, including bispecific/multi-specific antibodies, ADC, and new modalities. We are committed to building full capabilities covering the entire value chain of drug discovery and development, including novel discovery technology platform, translational medicine, CMC, clinical development and commercialization. VelaVigo is building its global R&D headquarter in Shanghai, and will set up R&D footprint globally. VelaVigo combines internal discovery/development and win-win partnership to drive its portfolio. We strive to the development of innovative, affordable biological drugs...
Biologics drug discovery and development,adc,new modalities,and bispecific/multi-specific antibodies
Velavigo operates in the Biotechnology research industry.
Velavigo's revenue is 11m - 100m
Velavigo has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.